Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taura syndrome virus (TSV) is a major pathogen belonging to the family Dicistroviridae, primarily impacting the Pacific white shrimp (Penaeus vannamei) (Source: OIE, 2019). The TSV genome consists of a single-stranded, positive-sense RNA that encodes two large polyproteins: ORF1, which produces non-structural proteins like RNA-dependent RNA polymerase (RdRp), helicase, and protease, and ORF2, which produces structural capsid proteins VP1, VP2, and VP3 (Source: UniProt, P89873). These proteins are essential for the viral life cycle, including genome replication and the assembly of icosahedral virions that infect the cuticular epithelium of the host (Source: ICTV). In aquaculture, these proteins are targeted by experimental RNA interference (RNAi) therapies and DNA vaccines to induce protective immunity or silence viral gene expression (Source: PubMed, PMID: 15652311). Understanding the structure and function of these proteins is critical for developing diagnostic tools and biosecurity measures to control the spread of Taura syndrome, which can cause up to 95% mortality in affected shrimp populations.
RNA interference (RNAi) mediated gene silencing of viral mRNA to inhibit translation and replication, and antibody-mediated neutralization of structural capsid proteins to prevent viral entry into host cells (Source: PubMed, PMID: 15652311).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taura syndrome virus polyprotein (TSV polyprotein).